Page 29 - Johnson Consumer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Johnson & Johnson Consumer Health Presents New Data on Skincare for Cancer Patients at the American Academy of Dermatology VMX 2021 New Study Results Indicate a Daily Avena Sativa (Oat) Skincare Regimen Significantly Improves Itch and Dry Skin in Adults Undergoing Systemic Cancer Treatments News provided by Share this article Share this article SKILLMAN, N.J., April 23, 2021 /PRNewswire/ -- Johnson & Johnson Consumer Health today presented findings from one of the first clinical studies examining a daily skincare regimen as adjunctive therapy for cancer patients at the American Academy of Der...

Escalating Demand For Anti-aging and Anti-pollution Ranges The market is experiencing an accelerating demand for anti-aging products, like anti-wrinkle cream, face cream, serum, eye cream, and others. In addition, factors like pollution and hard water conditions are bombarding such products' needs. An ascending number of consumers in the market are becoming aware of pollution's impact on the skin. In the United Kingdom, nearly 80% of consumers are aware of the impact of lifestyle stresses on the skin. Thus, consumers are inclined toward spending on skincare treatments at a younger age. They ...

Press release content from Business Wire. The AP news staff was not involved in its creation. Worldwide Skincare Products Industry to 2026 - Escalating Demand For Anti-Aging and Anti-Pollution Ranges - ResearchAndMarkets.com April 16, 2021 GMT DUBLIN--(BUSINESS WIRE)--Apr 16, 2021-- The Global Skincare Products Market was valued at USD 140.92 billion in 2020 and is projected to grow at a CAGR of 4.69% during the forecast period 2021 - 2026. ADVERTISEMENT The COVID-19 pandemic influenced consumers’ spending habits and purchase decisions leading to a slight decline in the market growth by 1.1...

Share this article DAVIS, Calif., March 11, 2021 /PRNewswire/ -- Evolve BioSystems, Inc. today announces that its product, activated B. infantis EVC001, will be used in one of the largest international clinical studies on preventing type 1 diabetes (T1D) in genetically predisposed children.  The randomized, controlled, double-blind, multicenter trial will be conducted across eight major research centers in five European countries. The Leona M. and Harry B. Helmsley Charitable Trust is funding the study and the continuation of the established newborn screening with more than $30 million. ...

To print this article, all you need is to be registered or login on Mondaq.com. Welcome to our monthly roundup of regulatory and litigation highlights impacting the dietary supplement and personal care products industries. NAD tackled substantiation for " #1 Dermatologist Recommended" claims in a challenge involving L'Oreal's CeraVe moisturizer and use of syndicated survey data to support related claims. Health claim substantiation was front and center in a Council for Responsible Nutrition-led challenge involving glutathione and the level of evidence required to supp...